BBY
46
10
FLR
58
3
UNP
52
7
VRSN
53
-4
SE
61
-4
SO
53
-4
FE
50
-2
SLB
55
2
CCI
31
3
WM
79
3
COF
60
2
BF.B
33
2
AXP
71
2
MLM
57
6
HST
49
-9
TRIP
47
3
GE
67
2
BSX
67
-3
UA
50
-9
SIG
52
3
BBY
46
10
FLR
58
3
UNP
52
7
VRSN
53
-4
SE
61
-4
SO
53
-4
FE
50
-2
SLB
55
2
CCI
31
3
WM
79
3
COF
60
2
BF.B
33
2
AXP
71
2
MLM
57
6
HST
49
-9
TRIP
47
3
GE
67
2
BSX
67
-3
UA
50
-9
SIG
52
3
Financhill
Back

Cresco Labs 10K Form

Sell
7

CRLBF
Cresco Labs

Last Price:
1.09
Seasonality Move:
1.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRLBF News And Ratings

See the #1 stock for the next 7 days that we like better than CRLBF

CRLBF Financial Statistics

Sales & Book Value

Annual Sales: $770.89M
Cash Flow: $43.06M
Price / Cash Flow: 5.03
Annual Sales: $1.31
Price / Book: 0.83

Profitability

EPS (TTM): -0.19570
Net Income (TTM): $-67.43M
Gross Margin: $362.37M
Return on Equity: -16.74%
Return on Assets: -4.92%

Cresco Labs Earnings Forecast

Key Cresco Labs Financial Ratios

  • The Gross Profit Margin over the past 15 years for CRLBF is 47.01%.
  • The Selling, General & Administrative Expenses for CRLBF have been equal to 38.81% of Gross Profit Margin.
  • The Interest Expense is -36.03% of Operating Income.
  • The Net Earning history of CRLBF is -22.77% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 12 years.

Cresco Labs Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CRLBF
Website: crescolabs.com

Debt

Debt-to-Equity Ratio: 1.14
Current Ratio: 1.97
Quick Ratio: 1.31

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRLBF Technical Analysis vs Fundamental Analysis

Sell
7
Cresco Labs (CRLBF) is a Sell

Is Cresco Labs a Buy or a Sell?

  • Cresco Labs stock is rated a Sell
    The current Cresco Labs [CRLBF] share price is $1.09. The Score for CRLBF is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.